Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

Dalian Company Punished For Producing Unapproved Rabies Vaccine

March 13, 2009
-
Health, Law & Order

Progress has been made on the incident of the un-approved rabies vaccine produced by Dalian Jingang Andi Bio-products Company.

According to China's Xinhua News Agency, the State Food and Drug Administration has decided on the penalty to be imposed on DJABC which was reported to produce an unapproved drug by using nucleic acid in rabies vaccine for human use. It says that the company's business license will be revoked and its main principals will not be allowed to engage in drug production and operation for ten years.

In February 2009, Yan Jiangying, a representative of SFDA, stated that 11 batches of rabies vaccine for human use made by DJABC in 2008 had been identified with nucleic acid and the agency asked the company to recall all those batches of rabies vaccine it produced in the year.

Tags: Dalian, drug, Food and Drug Administration, Jingang Andi Bio-products Company, rabies, SFDA, vaccine

Readers also read this:

Caterpillar China R&D Center Gets LEED Gold Certification

November 16, 2010

China Province To Eliminate Disposable Amenities From Hotels

November 5, 2010

Unilever China Wins China Green Gold Award

November 4, 2010

ZTE Organizes CSR Conference In Sanya

November 3, 2010

ADB And Tongji University Establish Urban Knowledge Hub

November 2, 2010

Yingli Green Energy Expands Production Capacity

November 1, 2010
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2025 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network